Abstract
Purpose of Review
The purpose of this revision is to sumarize the most important clinical features of the autoimune retinopathies (AIRs).
Recent Findings
AIRs are a group of inflammatory conditions affecting the retina characterized by progressive unexplained visual loss, abnormalities and contraction in visual fields, photoreceptor and electroretinographic dysfunction, and the presence of circulating anti-retinal antibodies. The pathogenesis of AIR remains unclear and various antiretinal antibodies have been associated to the disease. The diagnosis of AIR is based on a particular clinical presentation along with the detection of serum antiretinal antibodies. Numerous anti-inflammatory therapeutic alternatives have been described for the treatment of AIR; nevertheless, there is no consensus on treatment protocol.
Summary
Because of its association with different types of malignant tumors, the early diagnosis, multi-disciplinary approach, and prompt treatment should be warranted.
Similar content being viewed by others
References
Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157(2):266-72 e1.
Canamary AM Jr, Takahashi WY, Sallum JMF. Autoimmune retinopathy: a review. Int J Retin Vitr. 2018;4:1.
Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;58(5):430–58.
Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008;30(2):127–34.
Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina. 2014;34(5):827–45.
Adamus G, Champaigne R, Yang S. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. Clin Immunol. 2020;210:108317.
Roels D, Ueno S, Talianu CD, Draganova D, Kondo M, Leroy BP. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. Doc Ophthalmol. 2017;135(3):233–40.
Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, et al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol. 2016;168:183–90.
Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev. 2003;2(2):63–8.
Lei B, Bush RA, Milam AH, Sieving PA. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci. 2000;41(1):262–6.
Stanwyck LK, Moussa K, Chan W, Aitken PA, Sobrin L. Lack of correlation between number of antiretinal antibodies and clinical outcome measures in autoimmune retinopathy patients. Ophthalmol Retina. 2019;3(11):1007–9.
Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol. 2005;139(5):780–94.
Sen HN, Grange L, Akanda M, Fox A. Autoimmune retinopathy: current concepts and practices (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2017;115:T8.
Abazari A, Allam SS, Adamus G, Ghazi NG. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012;153(4):750–6, 6 e1.
Lima LH, Greenberg JP, Greenstein VC, Smith RT, Sallum JM, Thirkill C, et al. Hyperautofluorescent ring in autoimmune retinopathy. Retina. 2012;32(7):1385–94.
Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:5.
Faez S, Loewenstein J, Sobrin L. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol. 2013;131(1):113–5.
Forooghian F. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol. 2016;170:241–2.
Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127(4):390–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Luiz Roisman and Julia Dutra Rossetto each declare no potential conflicts of interest.
Raquel Goldhardt is a Section Editor for Current Ophthalmology Reports.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Retina
Rights and permissions
About this article
Cite this article
Roisman, L., Rossetto, J.D. & Goldhardt, R. Autoimmune Retinopathy, Testing, and Its Controversies. Curr Ophthalmol Rep 9, 178–183 (2021). https://doi.org/10.1007/s40135-021-00276-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-021-00276-y